Until recently, GLP-1 medications for weight loss meant weekly injections — period. That changed in January 2026 when oral GLP-1 pills for weight management entered the U.S. market, and since then the question has shifted from "do I want a GLP-1?" to "which format do I want it in?"
Both formats deliver the same class of medication. But the differences in how they work, how effective they are, and what they demand from you as a patient are worth understanding.
How Injectable GLP-1s Work
Injectable GLP-1 medications — semaglutide (Wegovy) and tirzepatide (Zepbound) — are administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. The medication is absorbed directly into the bloodstream through subcutaneous tissue, bypassing the digestive system entirely.
This is the format backed by the largest body of clinical trial data. The STEP and SURMOUNT trials that established GLP-1s as transformative weight loss treatments used injectable formulations.
How Oral GLP-1s Work
Oral semaglutide (Rybelsus for diabetes, and the newer oral formulation approved for weight loss) uses an absorption enhancer called SNAC that protects the peptide from stomach acid and facilitates absorption through the stomach lining. The medication must be taken daily — not weekly — and the dosing requirements are strict:
- Take on an empty stomach with no more than 4 ounces of plain water
- Wait at least 30 minutes before eating, drinking anything else, or taking other medications
- Take at the same time each day
Compounded oral GLP-1 formulations — including sublingual troches and dissolvable tablets — have also entered the market. These use different absorption mechanisms and may have different efficacy profiles than the FDA-approved oral versions.
Efficacy Comparison
This is where the distinction matters most:
Injectable semaglutide 2.4 mg weekly: Approximately 15–17% average total body weight loss over 68 weeks in the STEP trials. The injectable format delivers the full dose with near-100% bioavailability.
Oral semaglutide (approved weight loss dose): The newer high-dose oral formulation has demonstrated weight loss approaching that of the injectable version, though the precise head-to-head comparison data is still evolving. Earlier lower-dose oral semaglutide (Rybelsus 14 mg) produced approximately 5–8% weight loss — significantly less than the injectable.
The bioavailability gap is real: only about 1% of oral semaglutide is actually absorbed, which is why the oral dose in milligrams is much higher than the injectable dose. The strict fasting requirements exist to maximize that small absorption window.
Side Effects: How They Compare
Both formats cause GI side effects — nausea, vomiting, diarrhea, constipation — because these are related to the mechanism of action, not the delivery method. However:
- Injectable: Side effects tend to spike 1–3 days after each weekly injection and then fade. Many patients experience a predictable "rough day" each week.
- Oral: Side effects are more constant since you're dosing daily, but may be milder at any given moment. The trade-off is consistency vs. intensity.
Practical Considerations
Convenience
Injectable wins on simplicity: One injection per week, no dietary restrictions around dosing. You can inject at any time of day.
Oral wins on needle avoidance: If you genuinely cannot tolerate needles, oral eliminates that barrier entirely. But the daily fasting requirement is its own form of inconvenience.
Cost
Brand-name pricing is comparable between formats. Compounded injectable semaglutide is generally the most affordable option, with some providers offering it from $99–149/month. Compounded oral formulations vary widely in price and availability.
Travel
Injectable medications require cold storage (refrigeration), which complicates travel. Oral medications are more travel-friendly — no ice packs, no TSA explanations, no refrigerator coordination at hotels.
Adherence
Weekly injections are easier to remember than daily pills. Missing a daily oral dose reduces the medication's effectiveness more immediately than skipping a weekly injection (which has a 7-day half-life that provides some buffer).
Embody
Injectable semaglutide with physician oversight
$149 first month, $299/mo after
Paid link · Compounded medications are not FDA-approved and are prepared by licensed pharmacies.
Who Should Consider Each Format
Injectable is likely better for: Patients who want maximum efficacy, don't mind needles, want the simplicity of once-weekly dosing, prefer the most extensively studied format, or are using compounded semaglutide for cost reasons.
Oral may be better for: Patients with severe needle phobia, frequent travelers who need portable medication, patients who prefer a daily routine over weekly injections, or those with access to the newer high-dose oral formulation through insurance.
The bottom line: if efficacy is your top priority and you can tolerate injections, the injectable format has a more established track record and simpler dosing protocol. If needle avoidance is a genuine barrier to treatment — not just a mild preference — oral GLP-1s make the medication accessible in a way that matters.
Compare Injectable GLP-1 Options
Paid links · Compounded medications are not FDA-approved.